| CCM group (n = 1761) | Control group (n = 3522) |
---|---|---|
Creatinine and electrolyte tests | ||
 Rate 2005-2009 | 55.8% | 52.4% |
 Rate 2010-2013 | 80.7% | 65.3% |
Beta-blocker therapy | ||
 Rate 2005-2009 | 45.0% | 43.0% |
 Rate 2010-2013 | 65.1% | 59.5% |
ACE/ARBs therapy | ||
 Rate 2005-2009 | 78.2% | 76.7% |
 Rate 2010-2013 | 81.0% | 80.2% |